The endoscopic ultrasound device is created by Pentax. The company launched the device in mid-September.
Dr. Gelrud used the device to view a tumor in the fundus of a patient’s stomach. He said, “Because this scope is smaller and more flexible, I was able to access the area without any difficulty.”
Gastro Health CEO Joseph Garcia said the new scope supports the practice’s efforts to use the latest technology whenever possible. He said, “We are proud to have been the first in the country to utilize this new, state-of-the-art technology that allows us to deliver the best possible care to our patients and be at the forefront in advancing the field of gastroenterology.”
Gastro Health is financially supported by Audax Private Equity.
More articles on surgery centers:
8 statistics on ASC leader pay: 53% make $120,000+
Surgery Partners sells select anesthesia services businesses: 4 details
Missouri joint venture ASC opens
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.